help button home button Am J Pathol ASIP WHAT IS IT?
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Feitelson, M. A.
Right arrow Articles by Duan, L. X.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Feitelson, M. A.
Right arrow Articles by Duan, L. X.

American Journal of Pathology, Vol 150, 1141-1157, Copyright © 1997 by American Society for Investigative Pathology


REVIEWS

Hepatitis B virus X antigen in the pathogenesis of chronic infections and the development of hepatocellular carcinoma

MA Feitelson and LX Duan
Department of Pathology, Anatomy, and Cell Biology, Thomas Jefferson University, Philadelphia, Pennsylvania 19107-6799, USA.

Chronic infection with hepatitis B virus is associated with a high incidence of liver diseases, including hepatocellular carcinoma. Hepatitis-B-virus-encoded X antigen (HBxAg) stimulates virus gene expression and replication, which may be important for the establishment and maintenance of the chronic carrier state. Integration of viral DNA encoding HBxAg during chronic infection results in increased X antigen expression. HBxAg overexpression may alter signal transduction pathways important for the regulation of cell growth during hepatocellular regeneration. The finding that HBxAg binds to and inactivates negative growth-regulatory molecules, such as the tumor suppressor p53, suggests additional ways that HBxAg may act in hepatocarcinogenesis. HBxAg may also stimulate the expression of positive growth regulators, such as insulin-like growth factor II and the insulin-like growth factor I receptor. The finding that HBxAg may compromise DNA repair and that it may effect the normal turnover of growth-regulatory molecules in the proteasome may also contribute to its carcinogenic properties. Hence, HBxAg may contribute to the pathogenesis of chronic infection and development of hepatocellular carcinoma in a variety of ways.


This article has been cited by other articles:


Home page
QJMHome page
R. Kumar, M. K. Saraswat, B. C. Sharma, P. Sakhuja, and S.K. Sarin
Characteristics of hepatocellular carcinoma in India: a retrospective analysis of 191 cases
QJM, June 1, 2008; 101(6): 479 - 485.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
X. Liu, L. Wang, S. Zhang, J. Lin, S. Zhang, M. A. Feitelson, H. Gao, and M. Zhu
Mutations in the C-terminus of the X protein of hepatitis B virus regulate Wnt-5a expression in hepatoma Huh7 cells: cDNA microarray and proteomic analyses
Carcinogenesis, June 1, 2008; 29(6): 1207 - 1214.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
R. W. C. Pang, J. W. Joh, P. J. Johnson, M. Monden, T. M. Pawlik, and R. T. P. Poon
Biology of Hepatocellular Carcinoma
Ann. Surg. Oncol., April 1, 2008; 15(4): 962 - 971.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
J. Pan, Z. Lian, S. Wallet, and M. A. Feitelson
The hepatitis B x antigen effector, URG7, blocks tumour necrosis factor {alpha}-mediated apoptosis by activation of phosphoinositol 3-kinase and beta-catenin
J. Gen. Virol., December 1, 2007; 88(12): 3275 - 3285.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
D. R. Crawford, S. Ostrowski, D. Vakharia, Z. Ilic, and S. Sell
Separate Origins of Hepatitis B Virus Surface Antigen-Negative Foci and Hepatocellular Carcinomas in Transgenic HBsAg (alb/psx) Mice
Am. J. Pathol., July 1, 2006; 169(1): 223 - 232.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
H.-W. L. Hann, J. Lee, A. Bussard, C. Liu, Y. R. Jin, K. Guha, M. M. Clayton, K. Ardlie, M. J. Pellini, and M. A. Feitelson
Preneoplastic Markers of Hepatitis B Virus-Associated Hepatocellular Carcinoma
Cancer Res., October 15, 2004; 64(20): 7329 - 7335.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. I. Lee, J. M. Hwang, J. H. Im, Y. I. Lee, N. S. Kim, D. G. Kim, D. Y. Yu, H. B. Moon, and S. K. Park
Human Hepatitis B Virus-X Protein Alters Mitochondrial Function and Physiology in Human Liver Cells
J. Biol. Chem., April 9, 2004; 279(15): 15460 - 15471.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
G.-Y. Hwang, C.-Y. Lin, L.-M. Huang, Y.-H. Wang, J.-C. Wang, C.-T. Hsu, S.-S. Yang, and C.-C. Wu
Detection of the Hepatitis B Virus X Protein (HBx) Antigen and Anti-HBx Antibodies in Cases of Human Hepatocellular Carcinoma
J. Clin. Microbiol., December 1, 2003; 41(12): 5598 - 5603.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
P. A. Norton, Q. Gong, A. S. Mehta, X. Lu, and T. M. Block
Hepatitis B Virus-Mediated Changes of Apolipoprotein mRNA Abundance in Cultured Hepatoma Cells
J. Virol., May 1, 2003; 77(9): 5503 - 5506.
[Abstract] [Full Text] [PDF]


Home page
Toxicol PatholHome page
Qin Su and P. Bannasch
Relevance of Hepatic Preneoplasia for Human Hepatocarcinogenesis
Toxicol Pathol, January 1, 2003; 31(1): 126 - 133.
[Abstract] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
S.-Y. Chen, C.-J. Chen, S.-R. Chou, L.-L. Hsieh, L.-Y. Wang, W.-Y. Tsai, H. Ahsan, and R. M. Santella
Association of Aflatoxin B1-Albumin Adduct Levels with Hepatitis B Surface Antigen Status among Adolescents in Taiwan
Cancer Epidemiol. Biomarkers Prev., November 1, 2001; 10(11): 1223 - 1226.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
R. BREITKREUTZ, W. ZHANG, M. LEE, A. HOFFMANN, M. TOKUS, Q. SU, and C. H. SCHRODER
Hepatitis B Virus Nucleic Acids Circulating in the Blood: Distinct Patterns in HBs Carriers with Hepatocellular Carcinoma
Ann. N.Y. Acad. Sci., September 1, 2001; 945(1): 195 - 206.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
Q. Su, S.-F. Wang, T.-E. Chang, R. Breitkreutz, H. Hennig, K. Takegoshi, L. Edler, and C. H. Schroder
Circulating Hepatitis B Virus Nucleic Acids in Chronic Infection : Representation of Differently Polyadenylated Viral Transcripts during Progression to Nonreplicative Stages
Clin. Cancer Res., July 1, 2001; 7(7): 2005 - 2015.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
C. R. Madden, M. J. Finegold, and B. L. Slagle
Hepatitis B Virus X Protein Acts as a Tumor Promoter in Development of Diethylnitrosamine-Induced Preneoplastic Lesions
J. Virol., April 15, 2001; 75(8): 3851 - 3858.
[Abstract] [Full Text]


Home page
J. Gen. Virol.Home page
J. Pan, L.-X. Duan, B. S. Sun, and M. A. Feitelson
Hepatitis B virus X protein protects against anti-Fas-mediated apoptosis in human liver cells by inducing NF-{{kappa}}B
J. Gen. Virol., January 1, 2001; 82(1): 171 - 182.
[Abstract] [Full Text]


Home page
J. Virol.Home page
C. R. Madden, M. J. Finegold, and B. L. Slagle
Expression of Hepatitis B Virus X Protein Does Not Alter the Accumulation of Spontaneous Mutations in Transgenic Mice
J. Virol., June 1, 2000; 74(11): 5266 - 5272.
[Abstract] [Full Text]


Home page
Am. J. Pathol.Home page
S.-L. Y. Feng, Y. Guo, V. M. Factor, S. S. Thorgeirsson, D. W. Bell, J. R. Testa, K. A. Peifley, and J. A. Winkles
The Fn14 Immediate-Early Response Gene Is Induced During Liver Regeneration and Highly Expressed in Both Human and Murine Hepatocellular Carcinomas
Am. J. Pathol., April 1, 2000; 156(4): 1253 - 1261.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
Y. Shintani, H. Yotsuyanagi, K. Moriya, H. Fujie, T. Tsutsumi, Y. Kanegae, S. Kimura, I. Saito, and K. Koike
Induction of apoptosis after switch-on of the hepatitis B virus X gene mediated by the Cre/loxP recombination system
J. Gen. Virol., December 1, 1999; 80(12): 3257 - 3265.
[Abstract] [Full Text]


Home page
J. Virol.Home page
Z. Hu, Z. Zhang, E. Doo, O. Coux, A. L. Goldberg, and T. J. Liang
Hepatitis B Virus X Protein Is both a Substrate and a Potential Inhibitor of the Proteasome Complex
J. Virol., September 1, 1999; 73(9): 7231 - 7240.
[Abstract] [Full Text]


Home page
J. Virol.Home page
S. Menne, J. Maschke, M. Lu, H. Grosse-Wilde, and M. Roggendorf
T-Cell Response to Woodchuck Hepatitis Virus (WHV) Antigens during Acute Self-Limited WHV Infection and Convalescence and after Viral Challenge
J. Virol., July 1, 1998; 72(7): 6083 - 6091.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. K. Ogden, K. C. Lee, and M. C. Barton
Hepatitis B Viral Transactivator HBx Alleviates p53-mediated Repression of alpha -Fetoprotein Gene Expression
J. Biol. Chem., September 1, 2000; 275(36): 27806 - 27814.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Diao, A. A. Khine, F. Sarangi, E. Hsu, C. Iorio, L. A. Tibbles, J. R. Woodgett, J. Penninger, and C. D. Richardson
X Protein of Hepatitis B Virus Inhibits Fas-mediated Apoptosis and Is Associated with Up-regulation of the SAPK/JNK Pathway
J. Biol. Chem., March 9, 2001; 276(11): 8328 - 8340.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. L. Allan, C. Albanese, R. G. Pestell, and J. LaMarre
Activating Transcription Factor 3 Induces DNA Synthesis and Expression of Cyclin D1 in Hepatocytes
J. Biol. Chem., July 13, 2001; 276(29): 27272 - 27280.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1997 by the American Society for Investigative Pathology.